AMPLIFON GROUP – Chairman Susan Carol Holland, CEO Franco Moscetti

The Amplifon Group is a worldwide leader in the distribution and fitting of customized hearing solutions, as well as an international benchmark in audiology. The Group is recognised for the excellence of its products and services, stemming from its innovative and technological expertise, constant investment in R&D, far-reaching distribution network and the special attention given to customers’ requirements via a combination of medical and retail skills. Founded in Milan in 1950, in the 1990s Amplifon launched a forward-looking internationalisation process that has enabled the company to develop and consolidate its leadership in the major European, North American and Asia- Pacific markets. Listed on the Stock Exchange since 2001 and present in 20 countries, the Amplifon Group has a 9% world market share, a network of 3,200 retail outlets, a network of 1,700 affiliated shops, 2,500 service centres and a workforce numbering almost 11,000. In future years the group will continue to consolidate its leadership through organic growth and further acquisitions. With professionalism and commitment, Amplifon will continue to pursue its important mission: giving back the complete functioning and joy of hearing living sounds to people who require this service, guaranteeing them full satisfaction in any hearing situation. https://www.amplifon.com/uk/

DOMPÉ FARMACEUTICI S.P.A. – Chairman Sergio Dompé

Founded in 1940, Dompé is a renowned Italian pharmaceutical company. The Group focuses its strategic approach on developing innovative therapeutic solutions for rare diseases in areas with specific medical needs, such as ophthalmology, diabetology, transplants and oncology. It pursues this objective by promoting and playing an active role in a network of excellence covering all areas of the pharmaceutical supply chain, including R&D, manufacturing and marketing. Clinical studies on its own molecules are carried out in collaboration with an international research network involving the participation of 65 highly specialised centres in Europe, the United States and Canada. Dompé also supports companies proven to be particularly dynamic on the therapeutic innovation front. In 2009 it joined Philogen, a company specialised in biopharmaceutical products for the treatment of cancer, rheumatoid arthritis and certain ophthalmic diseases. In 2012 it acquired Anabasis, a biotech firm that develops innovative rhNGF-based drugs. In the same year the company became the major shareholder of AAA – Advanced Accelerator Applications – a leading company in the field of molecular medicine. Dompé has always strived with skill and courage to turn its eff orts into innovative solutions to improve human health. www.dompe.com

KERAKOLL SPA – CEO Gian Luca Sghedoni

Led by Gian Luca Sghedoni with an innovative vision combining business and corporate social responsibility, Kerakoll is the only company in the world that offers a GreenBuilding solution aimed at designing and building comfortable and environmental-friendly homes. GreenBuilding is a new construction method Kerakoll has successfully promoted around the world based on innovative studies regarding the biomedical field, materials technology and environmental impact that are carried out at the futuristic Kerakoll GreenLab, the world’s most advanced construction sector research centre. Indeed, Kerakoll has always allocated its best resources, equivalent to 5.4% of annual turnover, to green research. The group employs 1,350 people, with an average age of 35, and operates via 12 operating companies and 10 manufacturing plants. Kerakoll has been the technical supplier for important architectural projects, including: the Green Point Stadium in Cape Town, the European Court of Human Rights in Strasbourg, the Innova Design Center in Houston, the World Trade Center in Manama, the Allianz Arena in Munich, the Maxxi Museum in Rome, New Delhi International Airport, the Bird’s Nest Olympic Stadium in Beijing, the Coliseum in Rome, the Verona Arena, the Pitti Palace in Florence and the Palace of Venaria. www.kerakoll.com

MOSSI GHISOLFI – Chairman Vittorio Ghisolfi

The Mossi Ghisolfi Group, which was founded in 1953 by Vittorio Ghisolfi, is an Italian multinational operating in the chemicals sector and based in Tortona in Piedmont. With an annual turnover of US$3 billion, a workforce of 2,300 and more than 150 researchers, it ranks as Italy’s second chemicals company and is also present in the USA, Mexico, Brazil, China and India. The group’s activities break down into the following areas of business: PET – raw materials and engineering relating to plants for these products. This area includes Chemtex and other subsidiaries of M&G Chemicals, which operate in the Americas and Asia. Chemtex specialises in the design and construction of plants for the production of chemical compounds. The second area is biofuels, which are chemical products derived from non-food biomass and engineering relating to these plants. Biochemtex, Beta Renewables, Biochemtex Agro and IBP operate in this area. Operations regarding renewables are primarily carried out in Italy. The other areas are polyester fibre, a business that operates exclusively in Brazil, and Polimeri Italia, regarding PET resin production exclusively for the European market, and biodegradable polymers, with a plant located in Patrica (Frosinone), Italy. www.gruppomg.com